Siemens Healthcare’s thyroid-stimulating immunoglobulin assay for the diagnosis of Graves’ disease, a common cause of hyperthyroidism, has been cleared by the FDA. The Immulite 2000/2000 XPi TSI assay detects the presence of thyroid-stimulating antibodies only, making the differential diagnosis of Graves’ disease faster and more accurate, according to the company. Incorporating the TSI assay into […]